dirk dittmer

Professor

University of North Carolina

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Dirk Dittmer is a Professor at the University of North Carolina, USA. His research primarily focuses on herpesviruses, particularly Kaposi sarcoma-associated herpesvirus (KSHV) and its role in cancer and cellular dynamics. Recent publications explore topics such as epithelial-to-mesenchymal transition influenced by viral infections and the implications of inflammation in Kaposi sarcoma. Additionally, Dr. Dittmer investigates the evolution of KSHV and its interactions with host cellular mechanisms.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (5)

Robert Tomko Jr.

Associate Professor (tenured)

University of Florida College of Medicine

UNITED STATES

View details

Cliona M. Rooney

Baylor College of Medicine

UNITED STATES

View details

Tim Sauer

Heidelberg University

GERMANY

View details

Elizabeth Chiao

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Blossom Damania

University of North Carolina at Chapel Hill

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

dirk dittmer

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles.

KSHV and HPV modulate epithelial-to-mesenchymal transition in oral epithelial cells

Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV)

Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV)

Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma

The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice

CD81 fusion alters SARS-CoV-2 Spike trafficking

Is inflammation key in Kaposi sarcoma?

Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?

Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency

Cardiovascular Disease and Thrombosis in HIV Infection

A prospective cohort study identifies two types of HIV plus Kaposi Sarcoma lesions: proliferative and inflammatory

Scaling Biosafety Up During and Down After the COVID-19 Pandemic

AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma

Exosome-Encased Nucleic Acid Scaffold Chemotherapeutic Agents for Superior Anti-Tumor and Anti-Angiogenesis Activity

Whole-genome sequencing of Kaposi sarcoma-associated herpesvirus (KSHV/HHV8) reveals evidence for two African lineages

Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells

The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation

Combined Inhibition of Akt and mTOR Is Effective Against Non-Hodgkin Lymphomas

Collaborators (5)

Robert Tomko Jr.

Cliona M. Rooney

Tim Sauer

Elizabeth Chiao

Blossom Damania

Make your next move.